about
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisA structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunityA Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell RecognitionA T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I moleculeImpact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infectionNatural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognitionThe shaping of T cell receptor recognition by self-toleranceT cell allorecognition via molecular mimicryHard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptabilityAllelic polymorphism in the T cell receptor and its impact on immune responsesGenetic and Structural Basis for Selection of a Ubiquitous T Cell Receptor Deployed in Epstein-Barr Virus InfectionPeptide length determines the outcome of TCR/peptide-MHCI engagementA structural basis for varied αβ TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 moleculeThe impact of a large and frequent deletion in the human TCR β locus on antiviral immunityHighly Divergent T-cell Receptor Binding Modes Underlie Specific Recognition of a Bulged Viral Peptide bound to a Human Leukocyte Antigen Class I MoleculeThe Energetic Basis Underpinning T-cell Receptor Recognition of a Super-bulged Peptide Bound to a Major Histocompatibility Complex Class I MoleculeImmune self-reactivity triggered by drug-modified HLA-peptide repertoireMolecular Imprint of Exposure to Naturally Occurring Genetic Variants of Human Cytomegalovirus on the T cell RepertoireA Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen MicropolymorphismHLA peptide length preferences control CD8+ T cell responsesT Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ CellsT-cell allorecognition: a case of mistaken identity or déjà vu?The influence of antiviral T-cell responses on the alloreactive repertoire.A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.CD8+ T cells from a novel T cell receptor transgenic mouse induce liver-stage immunity that can be boosted by blood-stage infection in rodent malaria.Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation.Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors.Naive CD8⁺ T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamicsDominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigenInterleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing.The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaEngineered T cell receptors and their potential in molecular medicine.T cell allorecognition and MHC restriction--A case of Jekyll and Hyde?T-cell receptor bias and immunity.Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells
P50
Q24657081-CBFAA375-6186-476F-9B99-0F69A6C6A4CCQ27640322-784E02C6-7CDC-4F50-8DCC-D1BC1392900CQ27641906-27A06E4D-E671-49FE-8C20-B577CBCB5DC2Q27643687-61843B35-96CD-4BB3-BD02-61BF903F3CBDQ27649840-D64465AB-5671-4399-85A6-5824BF674157Q27653404-7ABA8DFF-905A-4A4F-B6CF-1BDC36A8A02AQ27653508-6C123ECE-07A7-4822-8D86-6321E2B48BC3Q27658914-AAB63C1B-18D8-47A9-9BF7-5C354EF89D79Q27661747-2C5CD5B7-8574-4807-8426-4509276BE724Q27662550-802FE1D4-B7CD-4059-9F6E-121E4637C5A9Q27666160-38564F8C-0AAE-42DF-9BC1-ED2312D0ADCAQ27675544-7DCD0B69-F6D6-4331-92FF-70B3DCB1EFA0Q27675980-BDE9DF56-6DE9-4DD6-9959-4384A0DCD845Q27677182-FF337D5D-1526-44CD-9CCE-DA61B7C93DB0Q27677256-0D146230-D07A-417B-A8A5-F9171D6EFC49Q27677334-75F7543A-C4A3-43B4-B35E-8687D88A38AFQ27681301-B8E04203-E071-48D1-B6F5-81AB67A408A2Q27681653-48248D51-5784-42F1-9927-3581545FCB26Q27683527-412DC144-4D28-4B11-8A78-4DFE57942631Q27684796-7F73FAD6-327B-41C1-B4C1-AD071AD7F51BQ27700158-1564ADF2-6DFB-4309-B871-3668A9C07314Q33345391-EB958AC1-06DE-4ABB-A851-BE874F154664Q33632723-06320050-8431-497D-A4D4-C388B4185AFEQ34044757-7C2F23E3-27FA-4FFA-BBCE-27CA77A1F878Q35132238-DE9EDABF-C333-4779-B797-446300C39887Q35172830-45A097C0-DBC1-46D4-BCC0-0017FA671490Q35181874-2B1CF2C3-34B8-412F-A1B2-41C398CC4B5FQ35621782-666D2460-D02C-4C43-AC1E-7D296668C4F1Q35665981-1763C06B-F0AE-4083-B0DD-E264298AE0E4Q35914856-98CCCF75-614A-4033-AACB-78E4AEC605B3Q35942594-3ECF890C-4155-467E-947E-BD2B09D4B70FQ36364099-E67D56A7-00FF-4153-99FC-33A6689CCBA0Q36365637-B2005286-68C3-48AF-9799-C7502F23F637Q36367105-99EFF4F1-5A15-4C3A-BD9E-54809809B7F9Q36403686-8AD78C3E-C72A-40EF-B329-F281E2DDD0EDQ36457849-A19AB1B9-F332-46DC-87F4-FCDCB02C28DBQ36638576-FFC057E1-8C34-4BDB-9D58-8B9085065567Q36942339-D5B36FA6-2495-41BC-8E5B-5B3F6B5336FDQ37061390-BAB77EC5-56CD-4FEE-AE53-7330C5A0C9A4Q37101168-484640CA-69F4-4892-B19B-6D7B2A13DFC8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Scott R Burrows
@ast
Scott R Burrows
@en
Scott R Burrows
@es
Scott R Burrows
@nl
Scott R Burrows
@sl
type
label
Scott R Burrows
@ast
Scott R Burrows
@en
Scott R Burrows
@es
Scott R Burrows
@nl
Scott R Burrows
@sl
prefLabel
Scott R Burrows
@ast
Scott R Burrows
@en
Scott R Burrows
@es
Scott R Burrows
@nl
Scott R Burrows
@sl
P106
P21
P31
P496
0000-0002-1430-0472